Upfront Diagnostics has embarked on the final phase of clinical trials in UK hospitals evaluating the use of its point-of-care rapid blood test for stroke.
The clinical study is being led by the Newcastle University Stroke Research Group in the UK.
The portable rapid blood test called LVOne, can detect in minutes strokes caused by a blood clot blocking a main vessel. This type of stroke is known as a large vessel occlusion (LVO).
